T. A. Ban
About
In The Last Decade
T. A. Ban
68 papers receiving 572 citations
Peers
Comparison fields: 5 of 96
- Psychiatry and Mental health 276
- Pharmacology 155
- Cellular and Molecular Neuroscience 128
- Molecular Biology 105
- Clinical Psychology 78
Countries citing papers authored by T. A. Ban
This map shows the geographic impact of T. A. Ban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. A. Ban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. A. Ban more than expected).
Fields of papers citing papers by T. A. Ban
This network shows the impact of papers produced by T. A. Ban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. A. Ban. The network helps show where T. A. Ban may publish in the future.
Co-authorship network of co-authors of T. A. Ban
This figure shows the co-authorship network connecting the top 25 collaborators of T. A. Ban. A scholar is included among the top collaborators of T. A. Ban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. A. Ban. T. A. Ban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 59 | |
| 3 | 50 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study. | 2 |
| 9 | 3 | |
| 10 | A double-blind comparative clinical trial with maprotiline (Ludiomil) and imipramine in newly-admitted depressed patients. | 6 |
| 11 | A clinical trial with nomifensin, a new antidepressant drug. | 10 |
| 12 | 4 | |
| 13 | 36 | |
| 14 | 12 | |
| 15 | A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital. | 11 |
| 16 | 1 | |
| 17 | 4 | |
| 18 | 2 | |
| 19 | 6 | |
| 20 | 50 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.